Clinical Trials Directory

Trials / Completed

CompletedNCT02767180

Evaluation of an ICU-specific Questionnaire for Patient-reported Outcome Measures

Evaluation of an Intensive Care Specific Questionnaire for Patient-reported Outcome

Status
Completed
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Sahlgrenska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

An ICU-specific questionnaire for patient reported outcome measures (PROM) after critical care will be tested in a study of 650 patients recruited six months to three years after discharge from the ICU, and 150 controls who have not been critically ill, matched for age and sex. The questionnaire is sent by mail after an invitation letter followed by a phone call and returned in a pre-stamped envelope. It is then scanned and data imported digitally. Medical data from the ICU-stay can be added. Further analyses after comparison with the control population and item reduction will follow.

Detailed description

ICU-patients were interviewed in a semi-structured way, providing detailed information on symptoms and difficulties in all areas of everyday life. The interviews were recorded, transcribed, and the issues were categorized into 13 hypothesised domains.All issues were then rephrased into questions, with care taken to maintain only one issue per question, and adequate scales for frequency, intensity and duration was used. The time frame is usually the last month. This intensive care specific questionnaire for patient reported outcome measures (PROM) after critical care will be tested in a study of 650 patients recruited six months to three years after discharge from the ICU, and 150 controls who have not been critically ill, matched for age and sex. The questionnaire is sent by mail after an invitation letter followed by a phone call and returned in a pre-stamped envelope. It is then scanned and data imported digitally. Medical data from the ICU-stay can be added. Further analyses after comparison with the control population and item reduction will follow.

Conditions

Timeline

Start date
2016-04-01
Primary completion
2020-04-01
Completion
2020-09-01
First posted
2016-05-10
Last updated
2020-10-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02767180. Inclusion in this directory is not an endorsement.